Skip to main content
. 2019 Mar 28;47(5):2116–2125. doi: 10.1177/0300060519834815

Figure 1.

Figure 1.

Serum microRNA (miR)-142-3p level in patients with colorectal cancer (CRC) and healthy controls. The serum miR-142-3p levels of 363 patients with CRC was significantly lower than that of 156 age-matched healthy volunteers (p < 0.01). The box indicates the interquartile range, the line indicates the median, and the whiskers indicate the standard deviation.